Disc Medicine IRON Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $188.78M+10.6% | $170.64M+14.4% | $149.21M+20.8% | $123.56M+22.7% | $100.73M+4.2% | ||
| $76.82M+17.5% | $65.38M+20.2% | $54.39M+20.3% | $45.2M+20.6% | $37.47M+13.4% | ||
| $265.6M+12.5% | $236.02M+15.9% | $203.6M+20.6% | $168.76M+22.1% | $138.2M+6.5% | ||
| $3.55M-1.5% | $3.61M+9.4% | $3.3M+38.5% | $2.38M+61.9% | $1.47M+157% | ||
| $24.29M+0.4% | $24.2M+5.5% | $22.94M-3.8% | $23.84M+7.5% | $22.18M+7.1% | ||
| $293K-18.8% | $361K-19.6% | $449K-2.6% | $461K-1.7% | $469K+32.1% | ||
| -$241.6M-13.9% | -$212.18M-17.2% | -$181.11M-24.6% | -$145.39M-24.8% | -$116.49M-6.5% | ||
| -$6.62-10.5% | -$5.99-12.0% | -$5.35-19.7% | -$4.47-14.0% | -$3.92+1.8% | ||
| -$265.25M-12.5% | -$235.74M-15.9% | -$203.4M-20.6% | -$168.64M-22.2% | -$138.05M-6.6% | ||
| -$265.6M-12.5% | -$236.02M-15.9% | -$203.6M-20.6% | -$168.76M-22.1% | -$138.2M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.